Zotepine
Alternative Names: Lodopin; Nipolept; ZoleptilLatest Information Update: 18 May 2020
At a glance
- Originator Astellas Pharma
- Developer Abbott GmbH & Co. KG; Astellas Pharma; Sanofi
- Class Antipsychotics; Dibenzothiepins
- Mechanism of Action Adrenergic receptor antagonists; Dopamine D1 receptor antagonists; Dopamine D2 receptor antagonists; Serotonin 5-HT2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Schizophrenia
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 11 Apr 2005 Yamanouchi has merged with Fujisawa to form Astellas Pharma
- 26 Aug 2004 Aventis has merged with Sanofi-Synthelabo to form Sanofi-Aventis